Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids

Lange's handbook of chemistry

Lange, N. A., & Speight, J. G. (1992) · Choice Reviews Online · doi:10.5860/choice.30-1849 · Cited by 7,163

STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES

Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,438

Structure of 20S proteasome from yeast at 2.4Å resolution

Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,265

Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution

Löwe, J., Stock, D., Jap, B. K., Zwickl, P., Baumeister, W. P., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,540

Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.

Kettner, C. A., & Shenvi, A. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42521-x · Cited by 294

The selective inhibition of thrombin by peptides of boroarginine.

Kettner, C. A., Mersinger, L. J., & Knabb, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44751-x · Cited by 254

Inhibition of serine proteases by peptidyl fluoromethyl ketones

Imperiali, B., & Abeles, R. H. (1986) · Biochemistry · doi:10.1021/bi00361a005 · Cited by 248

R-1-Acetamido-2-phenylethaneboronic acid. A specific transition-state analog for chymotrypsin

Matteson, D. S., Sadhu, K. M., & Lienhard, G. E. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00407a051 · Cited by 153

Design, synthesis, and kinetic evaluation of a unique class of elastase inhibitors, the peptidyl .alpha.-ketobenzoxazoles, and the x-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazole

Edwards, P. D., Meyer, E. F., Vijayalakshmi, J., Tuthill, P. A., Andisik, D., Gomes, B. C., & Strimpler, A. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00031a046 · Cited by 145

Kinetic Characterization of the Chymotryptic Activity of the 20S Proteasome

Stein, R. L., Melandri, F. D., & Dick, L. R. (1996) · Biochemistry · doi:10.1021/bi952262x · Cited by 138

New insights into proteasome function: from archaebacteria to drug development

Goldberg, A. L., Stein, R. L., & Adams, J. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90182-5 · Cited by 134

Purification and Characterization of a Z-Leu-Leu-Leu-MCA Degrading Protease Expected to Regulate Neurite Formation: A Novel Catalytic Activity in Proteasome

Tsubuki, S., Kawasaki, H., Saito, Y., Miyashita, N., Inomata, M., & Kawashima, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2378 · Cited by 120

Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation

Deshaies, R. J. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89102-3 · Cited by 84

Potent Inhibitors of Proteasome

Iqbal, M. A., Chatterjee, S., Kauer, J. C., Das, M. K., Messina, P. A., Freed, B., Biazzo, W., & Siman, R. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00013a002 · Cited by 68

Chapter 28. Novel Inhibitors of the Proteasome and Their Therapeutic Use in Inflammation

Adams, J., & Stein, R. L. (1996) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60467-4 · Cited by 66

Active Site-directed Inhibitors of Rhodococcus 20 S Proteasome

Cormack, T. M., Baumeister, W. P., Grenier, L., Moomaw, C. R., Plamondon, L., Pramanik, B. C., Slaughter, C. A., Soucy, F., Stein, R. L., Zühl, F., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26103 · Cited by 62

Potent α-ketocarbonyl and boronic ester derived inhibitors of proteasome

Iqbal, M. A., Chatterjee, S., Kauer, J. C., Mallamo, J. P., Messina, P. A., Reiboldt, A., & Siman, R. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00014-5 · Cited by 45

Formation of vicinal tricarbonyl compounds by selective oxidation of ylides using potassium peroxymonosulfate

Wasserman, H. H., & Vu, C. B. (1990) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)97843-2 · Cited by 44

The conversion of car☐ylic acids to keto phosphorane precursors of 1,2,3-vicinal tricarbonyl compounds

Wasserman, H. H., Ennis, D. S., Blum, C. A., & Rotello, V. M. (1992) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)61111-5 · Cited by 43

Interaction of peptide boronic acids with elastase: Circular dichroism studies

Berry, S. C., Fink, A. L., Shenvi, A. B., & Kettner, C. A. (1988) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340040307 · Cited by 18

The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis

Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608

Proteasome inhibitors: valuable new tools for cell biologists.

Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,458

The proteasome: a suitable antineoplastic target

Adams, J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1361 · Cited by 1,214

Proteasome inhibitors: from research tools to drug candidates

Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,209

ChemInform Abstract: Potent and Selective Inhibitors of the Proteasome: Dipeptidyl Boronic Acids.

Adams, J., Behnke, M. L., CHEN, S., Cruickshank, A., Dick, L. R., Grenier, L., Klunder, J. M., MA, Y. ‐., Plamondon, L., & Stein, R. L. (1998) · ChemInform · doi:10.1002/chin.199821191 · Cited by 1

α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity

Benedik, N. S., Šterman, A., Smrdel, L., Pajk, S., Gobec, S., Časar, Z., Gobec, M., & Sosič, I. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02548 · Cited by 3

Synthesis, in Vitro and in Vivo Biological Evaluation, and Comprehensive Understanding of Structure−Activity Relationships of Dipeptidyl Boronic Acid Proteasome Inhibitors Constructed from β-Amino Acids

Zhu, Y., Wu, G., Zhu, X., Ma, Y., Zhao, X., Li, Y., Yuan, Y., Yang, J., Yu, S., Shao, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1009742 · Cited by 38

Synthesis, in Vitro and in Vivo Biological Evaluation, Docking Studies, and Structure−Activity Relationship (SAR) Discussion of Dipeptidyl Boronic Acid Proteasome Inhibitors Composed of β-Amino Acids

Zhu, Y., Zhu, X., Wu, G., Ma, Y., Li, Y., Zhao, X., Yuan, Y., Yang, J., Yu, S., Shao, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901407s · Cited by 39

Design, Synthesis, Biological Evaluation, and Structure−Activity Relationship (SAR) Discussion of Dipeptidyl Boronate Proteasome Inhibitors, Part I: Comprehensive Understanding of the SAR of α-Amino Acid Boronates

Zhu, Y., Zhao, X., Zhu, X., Wu, G., Li, Y., Ma, Y., Yuan, Y., Yang, J., Hu, Y., Ai, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005093 · Cited by 75